Abstract submission
is now open for the next EACPT Congress, to be held in Geneva 28-31 August
2013. The congress includes symposia, keynote lectures and peer-reviewed oral
and poster communications
Symposium
on PK/PD
modeling
Population pharmacokinetic and
pharmacodynamic modeling is used for exploratory analyses in the clinical
development of new drugs or during post-marketing studies. The advantages
of such an approach are the collection of data in the target population, the
assessment of the variability within this population and, hopefully, the
discovery of factors that control this variability. The present and future
developments of this discipline will be outlined with regard to regulatory
acceptance, extension to mechanistic-based and disease progression modeling,
and application to treatment optimization, exemplified by a panel of
illustrative studies.
2013
EACPT Congress
Over 900 participants are expected to attend including
health professionals, scientists, policy makers, biotechnology and
pharmaceutical professionals, and others with an interest
in basic and clinical pharmacology, pharmacotherapy,
drug discovery and development, regulatory affairs and related
areas.
See here for more on
key themes of the Congress.
EACPT Geneva 2013 Congress website www.eacpt2013.org
EACPT Geneva 2013 Congress website www.eacpt2013.org
No comments:
Post a Comment